By Editor • August 28, 2026 • 1 min read
AstraZeneca and Ionis Pharmaceuticals revealed an unexpected failure of their heart disease drug during a recent European Society of Cardiology conference. Alnylam Pharmaceuticals is reportedly monitoring the developments closely.
Source: www.statnews.com
#Alnylam #AstraZeneca #European Society of Cardiology #heart disease #Ionis
By Editor • August 28, 2026 • 2 min read
The Ebola outbreak in DRC highlights a critical struggle against misinformation and the need for community trust in health initiatives.
Read moreBy Editor • August 28, 2026 • 1 min read
Erasca announces Charles Fuchs as president of research and development, formerly chief medical officer at Tubulis.
Read moreBy Editor • August 28, 2026 • 1 min read
Anti-vaccine activists are targeting families of measles victims in Pennsylvania after RFK Jr. raised doubts about the deaths' authenticity.
Read more
